Precision Genome Engineering Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Precision Genome Engineering General Information

Description

Developer of gene therapies for severe genetic disorders. The company uses stem cells harvested from patient's bone marrow into which a healthy version of the disease causing gene is inserted.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 454 North 34th Street
  • Seattle, WA 98103
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 454 North 34th Street
  • Seattle, WA 98103
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Precision Genome Engineering Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Precision Genome Engineering‘s full profile, request access.

Request a free trial

Precision Genome Engineering Patents

Precision Genome Engineering Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2014273089-A1 A laglidadg homing endonuclease cleaving the c-c chemokine receptor type-5 (ccr5) gene and uses thereof Active 31-May-2013
AU-2014273089-B2 A laglidadg homing endonuclease cleaving the c-c chemokine receptor type-5 (ccr5) gene and uses thereof Active 31-May-2013
CA-2913871-A1 A laglidadg homing endonuclease cleaving the c-c chemokine receptor type-5 (ccr5) gene and uses thereof Active 31-May-2013
CA-2913871-C A laglidadg homing endonuclease cleaving the c-c chemokine receptor type-5 (ccr5) gene and uses thereof Active 31-May-2013
EP-3004149-A1 A laglidadg homing endonuclease cleaving the c-c chemokine receptor type-5 (ccr5) gene and uses thereof Active 31-May-2013 C12N15/907
To view Precision Genome Engineering’s complete patent history, request access »

Precision Genome Engineering FAQs

  • When was Precision Genome Engineering founded?

    Precision Genome Engineering was founded in 2006.

  • Where is Precision Genome Engineering headquartered?

    Precision Genome Engineering is headquartered in Seattle, WA.

  • What industry is Precision Genome Engineering in?

    Precision Genome Engineering’s primary industry is Pharmaceuticals.

  • Is Precision Genome Engineering a private or public company?

    Precision Genome Engineering is a Private company.

  • What is the current valuation of Precision Genome Engineering?

    The current valuation of Precision Genome Engineering is .

  • What is Precision Genome Engineering’s current revenue?

    The current revenue for Precision Genome Engineering is .

  • When was Precision Genome Engineering acquired?

    Precision Genome Engineering was acquired on 30-Jun-2014.

  • Who acquired Precision Genome Engineering?

    Precision Genome Engineering was acquired by Genetix Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process